National HealthCare Corporation
HealthcareAMEX:NHC · New York Stock Exchange American
+$1.77 today
Vol 0.09M · Avg 0.12M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
11.2%
avg 8.4%
ROIC
8.2%
avg 4.3%
ROA
7.9%
avg 5.5%
Analysis
ROE is currently the strongest return metric at 11.2% versus its period average of 8.4%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Stephen Fowler Flatt | CEO, President & Director | $1.88M | — | 70 | $22,636.05 | 0.14% |
Brian F. Kidd | Senior Vice President & Chief Financial Officer | $934,981.00 | — | 51 | $33,130.00 | 0.21% |
Josh A. McCreary | Senior Vice President, General Counsel & Secretary | $909,271.00 | — | 53 | $7,500.00 | 0.05% |
Anderson Flatt | Senior Vice President & Chief Information Officer | $845,940.00 | — | 64 | $22,636.05 | 0.14% |
Carl E. Adams | Founder | — | — | — | $3,500.00 | 0.02% |
Timothy J. Shelly | Senior Vice President of Operations | — | — | 58 | $1,294.00 | <0.01% |
Vicki L. Dodson | Senior VP of Patient Services & Chief Nursing Officer | — | — | 64 | $18,412.55 | 0.12% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$174,858.85
Sells
6
$4.07M
Net Sentiment
$3.90M
Net selling
Most Active
Shelly Timothy J.
2 transactions
Analysis
Insiders reported 1 buys worth $174,858.85 and 6 sells worth $4.07M over the last 12 months. That adds up to net selling of $3.90M. Shelly Timothy J. was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -3.6% | +12.1% (8yr)12 analysts |
| Revenue | N/A | N/A | +6.0% | +11.7% (8yr)12 analysts |
| Net Income | N/A | N/A | -3.6% | +15.7% (8yr)12 analysts |
| EBIT | N/A | N/A | -0.5% | +15.0% (8yr)12 analysts |
Analysis
Recent growth has been strongest in Revenue at +6.0% over three years. Forward estimates point to Net Income at +15.7% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
LifeStance Health Group, Inc.
NASDAQ:LFST
$3.30B
Brookdale Senior Living Inc.
NYSE:BKD
$3.21B
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.73B
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
$2.26B
Select Medical Holdings Corporation
NYSE:SEM
$2.07B
Pediatrix Medical Group, Inc.
NYSE:MD
$2.00B
Astrana Health, Inc.
NASDAQ:ASTH
$1.91B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.54B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
Who manages NHC?
National HealthCare Corporation (NHC) lists 7 active executives. The top listed executive is Stephen Fowler Flatt, CEO, President & Director.
Are NHC insiders buying or selling?
Recent insider activity shows net buying of $14.79M.
Explore More
Continue the stock analysis
Jump to another research area for this company.